A prospective QOL survey of carbon ion radiotherapy in 12 fractions for prostate cancer
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000037680
- Lead Sponsor
- Gunma University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 300
Not provided
1) History of radiation therapy in the pelvis. 2) Active double cancer (simultaneous double cancer and metachronous double cancer with a disease-free period of 5 years or less). However, lesions equivalent to intraepithelial cancer or intramucosal cancer that are judged to be cured by local treatment are not included in active double cancer. 3) Patients who have undergone prior endocrine therapy and deviate from the endocrine therapy combination rule according to the risk. 4) castration resistant at the time of enrollment. 5) Patients who refuse to use endocrine therapy according to risk. 6) Cases with serious complications 7) Medical doctors determine that the doctor in charge is inappropriate due to medical, psychological or other factors.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expanded Prostate Cancer Index Composite (EPIC) Short Form with 8 questions (SF-8) EuroQol 5 Dimension (EQ-5D(5L))
- Secondary Outcome Measures
Name Time Method